{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:51:37Z","timestamp":1790538697599,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.biomaterials.2010.01.147","type":"journal-article","created":{"date-parts":[[2010,2,27]],"date-time":"2010-02-27T04:31:00Z","timestamp":1267245060000},"page":"4382-4391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["In vitro and in vivo performance of a dual drug-eluting stent (DDES)"],"prefix":"10.1016","volume":"31","author":[{"given":"Yingying","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subbu S.","family":"Venkatraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy Y.C.","family":"Boey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eeva M.","family":"Lahti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.R.","family":"Umashankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabareeswaran","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmikant","family":"Khanolkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir","family":"Vaishnav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2010.01.147_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/07853890600643404","article-title":"Restenosis related to percutaneous coronary intervention has been solved?","volume":"38","author":"Kivel\u00e4","year":"2006","journal-title":"Ann Med"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.amjcard.2006.09.107","article-title":"Two-year serial coronary angiographic and intravascular ultrasound analysis of in-stent angiographic late lumen loss and ultrasonic neointimal volume from the TAXUS II trial","volume":"99","author":"Tsuchida","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib3","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/01.CIR.0000034447.02535.D5","article-title":"Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up","volume":"106","author":"Degertekin","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2007.04.022","article-title":"Release profiles in drug-eluting stents: issues and uncertainties","volume":"120","author":"Venkatraman","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib5","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/S0140-6736(08)60922-8","article-title":"Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of bate thrombosis","volume":"371","author":"Bavry","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib6","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.jacc.2006.03.019","article-title":"Drug-eluting stents and late adverse clinical outcomes lessons learned, lessons awaited","volume":"47","author":"Tsimikas","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib7","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/01.CIR.0000086926.62288.A6","article-title":"Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions","volume":"108","author":"Colombo","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib8","first-page":"1373","article-title":"Preclinical restenosis models and drug-eluting stents: still important, still much to learn","volume":"44","author":"Schwartz","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib9","first-page":"782","article-title":"Stent thrombosis with drug-eluting stents: a re-examination of the evidence","volume":"69","author":"Gautam Kedia","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jacc.2004.09.079","article-title":"Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation","volume":"45","author":"Ong","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib11","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S1051-0443(99)70090-4","article-title":"Relationship between blood flow, thrombus, and neointima in stents","volume":"10","author":"Richter","year":"1999","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib12","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1161\/01.CIR.0000086347.31341.F9","article-title":"Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: final results of the HOPE (HEPACOAT and an antithrombotic regimen of aspirin alone) study","volume":"108","author":"Mehran","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/heart.83.3.338","article-title":"Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries","volume":"83","author":"Whelan","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib14","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.biomaterials.2006.11.020","article-title":"The short-term effects on restenosis and thrombosis of echinomycin-eluting stents topcoated with a hydrophobic heparin-containing polymer","volume":"28","author":"Lee","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib15","unstructured":"Venkatraman S, Boey F and Khanolkar L. A non-biodegradable stent comprising a biodegradable coating and a method of coating the same. PCT Patent Application No. PCT\/SG2008\/000413, 2007."},{"key":"10.1016\/j.biomaterials.2010.01.147_bib16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jchromb.2003.09.049","article-title":"Simultaneous determination of triflusal and its major active metabolite, 2-hydroxy-4-trifluoromethyl benzoic acid, in rat and human plasma by high-performance liquid chromatography","volume":"798","author":"Cho","year":"2003","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/mabi.200400015","article-title":"Hydrophilic polymer drug from a derivative of salicylic acid: synthesis, controlled release studies and biological behavior","volume":"4","author":"Rodr\u00edguez","year":"2004","journal-title":"Macromol Biosci"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1146\/annurev.bioeng.2.1.9","article-title":"Physicochemical foundations and structural design of hydrogels in medicine and biology","volume":"2","author":"Peppas","year":"2000","journal-title":"Annu Rev Biomed Eng"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib19","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/S0142-9612(00)00115-0","article-title":"The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide) (PLGA) devices","volume":"21","author":"Jain","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0168-3659(91)90027-B","article-title":"More about the degradation of LA\/GA-derived matrices in aqueous media","volume":"16","author":"Vert","year":"1991","journal-title":"J Control Release"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1540-8183.2009.00489.x","article-title":"The short-term effect on restenosis and thrombosis of a cobalt-chromium stent eluting two drugs in a porcine coronary artery model","volume":"22","author":"Huang","year":"2009","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0735-1097(92)90476-4","article-title":"Restenosis and the proportional neointimal response to coronary-artery injury \u2013 results in a porcine model","volume":"19","author":"Schwartz","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib23","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1161\/01.CIR.0000033485.20594.6F","article-title":"Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group","volume":"106","author":"Schwartz","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jconrel.2004.10.019","article-title":"Controlled release from bioerodible polymers: effect of drug type and polymer composition","volume":"102","author":"Frank","year":"2005","journal-title":"J Control Release"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib25","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/heart.83.4.462","article-title":"Coronary stent symmetry and vascular injury determine experimental restenosis","volume":"83","author":"Schulz","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1067\/mva.2002.122878","article-title":"Effect of endovascular stent strut geometry on vascular injury, myointimal hyperplasia, and restenosis","volume":"36","author":"Sullivan","year":"2002","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijcard.2008.01.057","article-title":"Glucocorticoids in the prevention of in-stent restenosis: the role of inflammation","volume":"135","author":"Celik","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib28","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.amjcard.2005.07.042","article-title":"Comparison of effects of drug-eluting stents versus bare metal stents on plasma C-reactive protein levels","volume":"96","author":"Kim","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib29","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1161\/01.ATV.16.10.1312","article-title":"Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin","volume":"16","author":"Rogers","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib30","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1161\/01.ATV.20.12.2553","article-title":"Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries","volume":"20","author":"Welt","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib31","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/hc3601.093987","article-title":"Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model","volume":"104","author":"Suzuki","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib32","doi-asserted-by":"crossref","first-page":"36M","DOI":"10.1016\/j.amjcard.2007.08.020","article-title":"The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents","volume":"100","author":"Nakazawa","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9149(03)00669-6","article-title":"Usefulness of a cobalt chromium coronary stent alloy","volume":"92","author":"Kereiakes","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00019501-200109000-00011","article-title":"Paclitaxel-coated Gianturco-Roubin II (GR II) stents reduce neointimal hyperplasia in a porcine coronary in-stent restenosis model","volume":"12","author":"Hong","year":"2001","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib35","first-page":"383","article-title":"Toxic vessel reaction to an absorbable polymer-based paclitaxel-eluting stent in pig coronary arteries","volume":"18","author":"Jabara","year":"2006","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib36","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.0000128850.84227.FD","article-title":"Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer","volume":"109","author":"Grube","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib37","first-page":"97","article-title":"Experimental efficacy of an everolimus eluting cobalt chromium stent","volume":"68","author":"Carter","year":"2006","journal-title":"Catheter and Cardiovasc Interv"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib38","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1055\/s-0037-1615973","article-title":"Does thrombus contribute to in-stent restenosis in the porcine coronary stent model?","volume":"85","author":"Lowe","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib39","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1023\/A:1008985302826","article-title":"New resorbable polymeric systems with antithrombogenic activity","volume":"10","author":"Rodriguez","year":"1999","journal-title":"J Mater Sci Mater Med"},{"key":"10.1016\/j.biomaterials.2010.01.147_bib40","series-title":"Frontiers in interventional cardiology","first-page":"95","article-title":"Stent design and the biologic response","author":"Garasic","year":"1997"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296121000195X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296121000195X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:18:23Z","timestamp":1758899903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014296121000195X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":40,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S014296121000195X"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2010.01.147","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in vivo performance of a dual drug-eluting stent (DDES)","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2010.01.147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}